Join Jackie Hunter, CEO BenevolentBio who will share her thoughts and her experience.
Join Mark Davies, VP Biomedical Informatics at BenevolentAI for a talk on "Disrupting Drug Discovery with AI"
Join the conversation on "Looking into the Future – Bio-Innovation in 20 Years" at Innovation Forum with Jackie Hunter CEO, BenevolentBio.
We are delighted to announce that BenevolentAI is a sponsor at NIPS conference this year. Our team of data scientists and machine learning researchers will be present on booth 124 and we look forward to meeting you and talking AI, super computers and deep tech.
Join Nasrin Mostafazadeh at the NLP Seminar Series organised at Stanford University on the 30 November
Join Ken Mulvany Founder and Chairman of BenevolentAI for a talk on "Can a machine cure brain disease"
Join Jerome Pesenti, CEO BenevolentTech for a debate on Future challenges: preparing for Artificial Intelligence
Join Gareth Jones, VP Intellectual Property at BenevolentAI at the Future of Tech IP Summit
Join Rabia T. Khan, Exploratory Scientist at BenevolentAI for a panel discussion on What makes a great researcher: tools and skills.
Join Patrick Keohane, CMO at BenevolentAI for a panel on Disruption from Afar: Embracing New Non-Pharma Technologies & Actors
Jackie Hunter, CEO BenevolentBio and Jerome Pesenti, CEO BenevolentTech will be joining Web Summit this year.
Patrick Keohane, Chied Medical Officer at BenevolentBio will be presenting at the BioData World Congress 2017
Join Jerome Pesenti, CEO BenevolentTech at Founder Forum for a panel on Artificial Intelligence
Jerome Pesenti, CEO at BenevolentTech will be joining Data Driven Event held at Bloomberg LP to discuss how BenevolentAI artificial intelligence can accelerate drug discovery
Join Jackie Hunter, CEO BenevolentBio for the relaunch of Bitesize PhD event series. On this occasion, Jackie will discuss her career and her experience and will answer questions.
Dean Plumbley, Senior Machine Learning Scientist at BenevolentAI will present on re-inventing the scientific method: how artificial intelligence is revolutionising drug discovery
Big Data is the process of analysing high volume, high velocity data by advanced computational methods that produce actionable knowledge...
Dan Neil, Lead Machine Learning Researcher at BenevolentAI discusses Tools, Frameworks and AI Systems Engineering: Survey of Tools and Frameworks
Jerome Pesenti, CEO BenevolentTech participated to the G7 debate around around challenges that innovation poses.
Join Gareth Jones, VP Intellectual Property BenevolentAI at the World IP Summit
Join Ken Mulvany and James Chandler at the CEC Capital Summit
The AI in Bioscience Symposium is an annual one day conference that aims to foster collaboration between experts in AI, technology, academia and the life sciences industry
Amir Saffari, Director of Applied AI will be discussing Machine Learning for Drug Discovery - Join the event
BenevolentAI will be sponsoring MLSB Workshop on Machine Learning in Systems Biology. Our team will be present and we encourage to get in touch. Job opportunities are opened.